The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody via Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events
暂无分享,去创建一个
Kazuhiro Sato | Hiroshi Tanaka | Aya Ohtsubo | Kosuke Ichikawa | T. Kikuchi | Satoshi Watanabe | K. Nozaki | H. Yoshizawa | S. Shoji | Rie Kondo | M. Okajima | T. Koya | S. Miura | T. Ishida | Masaki Terada | N. Aoki | T. Ota | M. Hayashi | T. Miyabayashi | N. Matsumoto | T. Abe | Toshiya Fujisaki | Kohei Kushiro | Yusuke Sato | Miho Takahashi | S. Hokari | A. Iwashima | Y. Ohshima | Y. Sato